BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29987501)

  • 1. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
    Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
    Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
    Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
    Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
    Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
    Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
    Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
    Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer.
    Gallardo-Rincón D; Toledo-Leyva A; Bahena-González A; Montes-Servín E; Muñoz-Montaño W; Coronel-Martínez J; Oñate-Ocaña LF
    Arch Med Res; 2020 Oct; 51(7):690-699. PubMed ID: 32768148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
    Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
    Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the functional assessment of anorexia/cachexia therapy instrument to assess quality of life in maintenance hemodialysis patients with cachexia.
    Yang Z; Luo Y; Lu H; Zou B; Wang H; Chen G; Wu Y; Huang Y
    Semin Dial; 2022 Jul; 35(4):330-336. PubMed ID: 35032061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.
    Gallardo-Rincón D; Toledo-Leyva A; Bahena-González A; Montes-Servín E; Pérez-Martín AR; Montes-Servín E; Alamilla-García GC; Carmona-Herrera DD; Coronel-Martínez J; Oñate-Ocaña LF
    Arch Gynecol Obstet; 2021 Sep; 304(3):773-782. PubMed ID: 33582853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the QLQ-CAX24 instrument in cervical cancer and its association with cachexia classifications.
    Luvián-Morales J; Castillo-Aguilar J; Delgadillo-González M; Cisneros-Sánchez A; Bosch-Gutiérrez J; Castro-Eguiluz D; Cetina-Pérez L; Oñate-Ocaña LF
    Jpn J Clin Oncol; 2023 Mar; 53(4):304-312. PubMed ID: 36579766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
    Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
    Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anorexia/cachexia-related quality of life for children with cancer.
    Lai JS; Cella D; Peterman A; Barocas J; Goldman S
    Cancer; 2005 Oct; 104(7):1531-9. PubMed ID: 16088963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers.
    Oñate-Ocaña LF; Velázquez-Monroy N; Vázquez L; Espinosa-Mireles-de-Villafranca P; Núñez-Rosas E; Ovando-Lezama M; Vilar-Compte D; García-Hubard G; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Psychooncology; 2012 Jul; 21(7):745-53. PubMed ID: 21538681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
    Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
    Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
    Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.